|
Market Closed -
Nasdaq
21:00:00 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 56.07 USD | -2.96% |
|
+0.47% | +41.73% |
| 09-24 | Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing | MT |
| 09-21 | AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 1000 | CI |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 2,939 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 49.43% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,787 | 2,712 | 2,618 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 48.83% | -2.68% | -3.47% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 541x | 137x | 83x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 5.08x | 4.52x | 3.96x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -4x | 0x | 1.3x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 4.85x | 4.32x | 3.84x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 4.6x | 3.99x | 3.42x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 31.9x | 26.7x | 21.1x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 243x | 109x | 61.5x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 52.9x | 66.8x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 1.89% | 1.5% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1068 | 0.4206 | 0.6961 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.3 | 679.7 | 765.4 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.49 | 101.7 | 124.2 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 24.98 | 42.55 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.132 | 20.89 | 35.25 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -151.9 | -226.6 | -320.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 57.78 | 57.78 | 57.78 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 15/02/22 | 21/02/23 | 15/02/24 | 12/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 540.86x | 4.6x | 31.86x | -.--% | 2.94B | |
| 30.89x | 4.09x | 15.79x | 2.46% | 181B | |
| 20.43x | 3.54x | 12.67x | 2.95% | 117B | |
| 22.83x | 4.47x | 15.61x | 1.23% | 112B | |
| 26.34x | 2.59x | 10.38x | 2.72% | 76.56B | |
| 18.73x | 0.22x | 13.57x | 0.7% | 65.15B | |
| 30.39x | 7.54x | 19.43x | 1.32% | 52.79B | |
| 37.34x | 3.56x | 12.2x | 2.02% | 52.78B | |
| 37.06x | 9.21x | 25.79x | -.--% | 43.11B | |
| 49.13x | 1.34x | 12.46x | 0.2% | 32.08B | |
| Average | 81.40x | 4.12x | 16.98x | 1.36% | 73.59B | |
| Weighted average by Cap. | 30.07x | 3.95x | 15.02x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
